Bausch Health has patented a method and composition for treating nail disorders. The patent involves a pharmaceutical composition containing specific ingredients like ethanol and antifungal agents for treating onychomycosis. The composition is applied topically to the affected nail once daily for effective treatment. GlobalData’s report on Bausch Health gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Bausch Health Companies Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Bausch Health, Cancer treatment biomarkers was a key innovation area identified from patents. Bausch Health's grant share as of January 2024 was 55%. Grant share is based on the ratio of number of grants to total number of patents.

Topical treatment for onychomycosis using specific pharmaceutical composition

Source: United States Patent and Trademark Office (USPTO). Credit: Bausch Health Companies Inc

A recently granted patent (Publication Number: US11872218B2) discloses a method for treating onychomycosis, a fungal infection of the nail, by topically applying a specific pharmaceutical composition once daily. The composition includes ethanol, diisopropyl adipate, C12-15 alkyl lactate, cyclomethicone, an antioxidant, and a triazole antifungal agent formulated as a solution. The application of this composition is aimed at ameliorating the symptoms associated with onychomycosis.

Furthermore, the patent claims specify the concentrations of each component in the composition, such as the presence of ethanol at a minimum of 50% (w/w), diisopropyl adipate and C12-15 alkyl lactate between 15% and 50% (w/w), and cyclomethicone at less than 25% (w/w). The triazole antifungal agent mentioned in the claims is detailed as (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidine-1-yl)-1-(1H-1,2,4-triazole-1-yl)butane-2-ol, present in the composition at specific concentrations. Notably, the composition does not contain a polymeric film forming compound, as emphasized in the patent claims.

To know more about GlobalData’s detailed insights on Bausch Health, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies